pankajmathur/National_Library_of_Medicine_Studies_data huggingface dataset:
Clinical trial: A Post-Market Clinical Evaluation of the ReUnion Reversible Fracture (RFX) System
Status: TERMINATED
Conditions: Arthroplasty|Hemiarthroplasty|Shoulder Pain
Interventions: DEVICE: ReUnion Total Shoulder Arthroplasty (TSA)|DEVICE: ReUnion Reverse Shoulder Arthroplasty (RSA)
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: Hematopoietic Stem Cell Transplantation and Childhood Leukemia Quality of Life in SIbling DONors
Status: UNKNOWN
Conditions: Hematopoietic/Lymphoid Cancer
Interventions: OTHER: questionnaire VSP-A
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: OTHER
Clinical trial: Impact of Regional Vibration Application and Flow Mediated Dilation on Brachial Artery Hemodynamics
Status: COMPLETED
Conditions: Vasodilation|Diabetes Mellitus, Type 2
Interventions: DEVICE: Local Vibration Application Following Flow Mediated Dilation|OTHER: Flow mediated dilation
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: BASIC_SCIENCE
Clinical trial: Phase II Trial With Metronomic, Capecitabine Plus Oral Vinorelbine for Metastatic Breast Cancer
Status: COMPLETED
Conditions: Breast Cancer
Interventions: DRUG: Arm B Vinorelbine (Navelbine oral) Capecitabine (Xeloda)|DRUG: Arm A Vinorelbine (Navelbine oral) Capecitabine (Xeloda)
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: PCB for Long De Novo Lesions of Main Coronary Arteries (D-Lesion Long Trial)
Status: UNKNOWN
Conditions: Stable Angina Pectoris|Unstable Angina Pectoris
Interventions: DEVICE: Paclitaxel-Coated Balloon
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: SARC024: A Blanket Protocol to Study Oral Regorafenib in Patients With Selected Sarcoma Subtypes
Status: COMPLETED
Conditions: Liposarcoma|Osteogenic Sarcoma|Ewing/Ewing-like Sarcoma|Rhabdomyosarcoma|Mesenchymal Chondrosarcoma
Interventions: DRUG: Regorafenib|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Neck-specific Training or Prescribed Physical Activity for Patients With Cervical Radiculopathy
Status: COMPLETED
Conditions: Cervical Pain|Pain, Radiating
Interventions: OTHER: Prescribed physical activity|OTHER: Neck specific training
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Maximal Use of Luliconazole Cream 1% in Pediatric Participants With Moderate to Severe Tinea Pedis or Tinea Cruris
Status: COMPLETED
Conditions: Tinea Pedis|Tinea Cruris
Interventions: DRUG: Luliconazole Cream 1%
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: The Combination Therapy of Fractional Laser and PRP Compared With Nanofat Grafting and PRP Synergy in Treating Striae Gravidarum.
Status: UNKNOWN
Conditions: Treatments of Striae Gravidarum
Interventions: DEVICE: Fractional CO2 Laser|PROCEDURE: Nanofat grafting|PROCEDURE: Platelet-rich plasma (PRP) Injection
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: DKI Combined With APT for Post-treatment Assessment of Ovarian Malignancies and Correlation With XRCC2 Gene
Status: NOT_YET_RECRUITING
Conditions: Malignant Tumor of the Ovary|XRCC2 Gene Mutation
Interventions: RADIATION: DKI and APT
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: Raltitrexed-based Chemotherapy Plus Bevacizumab in Retreated Patients With Advanced Colorectal Cancer
Status: UNKNOWN
Conditions: Advanced Colorectal Cancer
Interventions: DRUG: Raltitrexed|DRUG: Irinotecan|DRUG: Oxaliplatin|DRUG: Bevacizumab
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Defibrillation Testing During Implantable Cardioverter Defibrillator (ICD) Replacement
Status: COMPLETED
Conditions: Implantable Cardioverter-Defibrillators
Interventions: DIAGNOSTIC_TEST: Defibrillator threshold testing
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: PREVENTION
Clinical trial: Effects of Growth Hormone on Cognition and Cerebral Metabolism in Adults With Growth Hormone Deficiency
Status: COMPLETED
Conditions: Hypopituitarism
Interventions: DRUG: Human Growth Hormone (1-134)|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Study of Hydrogen Inhalation Compared With Placebo in Type 2 Diabetes Patients
Status: RECRUITING
Conditions: Type 2 Diabetes
Interventions: DEVICE: Hydrogen generator|DEVICE: Analogue machine
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Injection Techniques of Collagenase Clostridium Histolyticum (CCH) for the Treatment of EFP (Cellulite)
Status: COMPLETED
Conditions: Edematous Skin
Interventions: DRUG: collagenase clostridium histolyticum (CCH)
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: A Study in Healthy Men to Test How Well Different Doses of BI 1819479 Are Tolerated and Taken up by the Body With or Without Food
Status: COMPLETED
Conditions: Healthy
Interventions: DRUG: BI 1819479|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT
Clinical trial: Prevention of Paclitaxel-induced Peripheral Neuropathy in Breast Cancer Patients
Status: RECRUITING
Conditions: Peripheral Neuropathy Due to Chemotherapy
Interventions: DRUG: Losartan
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
Clinical trial: Talazoparib Plus Irinotecan With or Without Temozolomide in Children With Refractory or Recurrent Solid Malignancies
Status: COMPLETED
Conditions: Childhood Solid Tumors
Interventions: DRUG: Talazoparib|DRUG: Irinotecan|DRUG: Temozolomide|DRUG: Filgrastim|DRUG: Peg-filgrastim
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Effectiveness of the Transitional Care Model in Total Knee Arthroplasty Patients
Status: COMPLETED
Conditions: Knee Osteoarthritis|Pain|Self Efficacy|Health Care Utilization
Interventions: OTHER: Transitional care model
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE
Clinical trial: Neoadjuvant CAN-2409 in Combination With Chemoradiation or SBRT for Borderline Resectable Pancreatic Adenocarcinoma
Status: ACTIVE_NOT_RECRUITING
Conditions: Borderline Resectable Pancreatic Adenocarcinoma
Interventions: BIOLOGICAL: Aglatimagene besadenovec|RADIATION: Chemoradiation|RADIATION: Stereotactic body radiation therapy|PROCEDURE: Surgery
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Etoposide/Cisplatin Compared With Irinotecan/Cisplatin for Advanced Gastrointestinal Neuroendocrine Tumor G3 Type
Status: UNKNOWN
Conditions: Gastrointestinal Neuroendocrine Tumor
Interventions: DRUG: Etoposide|DRUG: Irinotecan
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: A Trial to Assess the Effect of Liraglutide on Gastric Emptying in Healthy Obese Volunteers
Status: COMPLETED
Conditions: Metabolism and Nutrition Disorder|Obesity
Interventions: DRUG: liraglutide|DRUG: liraglutide|DRUG: liraglutide|DRUG: liraglutide|DRUG: liraglutide|DRUG: liraglutide
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: The Significance of the Mesh Thickness in the Operation of Inguinal Hernia
Status: UNKNOWN
Conditions: Inguinal Hernia
Interventions: PROCEDURE: Lichtenstein operation with a heavy-weight mesh|PROCEDURE: Lichtenstein operation with a light-weight mesh
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: The Effects of a Head Elevated Ramped Position During Elective Cesarean Delivery After Combined Spinal Epidural (CSE) Anesthesia
Status: COMPLETED
Conditions: Cesarean Section
Interventions: DEVICE: TROOP® elevation pillow|DEVICE: TROOP® elevation pillow|DEVICE: TROOP® elevation pillow
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Allogeneic Stem Cell Transplantation for Children With CML
Status: COMPLETED
Conditions: Chronic Myeloid Leukemia
Interventions: DRUG: Fludarabine|DRUG: Thiotepa|DRUG: Melphalan|DRUG: ATG|DRUG: Cyclosporine A|DRUG: Mycophenolate mofetil|BIOLOGICAL: bone marrow or peripheral blood stem cells
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: The Effect of Alginate Encapsulated Supplements on Athletic Performance and Recovery
Status: RECRUITING
Conditions: Athletic Performance
Interventions: DIETARY_SUPPLEMENT: Slow-release CHO-AA|DIETARY_SUPPLEMENT: Slow-release CHO|DIETARY_SUPPLEMENT: CHO
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: OTHER
Clinical trial: Study Comparing the Tolerability of Seroquel IR With Seroquel XR in Patients With Bipolar Depression
Status: COMPLETED
Conditions: Bipolar Depression
Interventions: DRUG: Quetiapine Immediate Release|DRUG: Quetiapine Extended Release
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose:
Clinical trial: Nivolumab in Combination With Ipilimumab in Patients With Metastatic Renal Cell Carcinoma
Status: ACTIVE_NOT_RECRUITING
Conditions: Renal Cell Carcinoma
Interventions: DRUG: nivolumab|DRUG: ipilimumab
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Treatment of GHD Associated With CHF
Status: UNKNOWN
Conditions: Heart Failure|Growth Hormone Deficiency
Interventions: DRUG: Human growth hormone|OTHER: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: A Study of Selicrelumab (RO7009789) in Combination With Atezolizumab in Participants With Locally Advanced and/or Metastatic Solid Tumors
Status: COMPLETED
Conditions: Solid Tumors
Interventions: DRUG: Atezolizumab|DRUG: Selicrelumab
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Observational Study of Type 1 and Type 2 Diabetes Patients Having Switched From Human Premixes to NovoMix®30
Status: COMPLETED
Conditions: Diabetes|Diabetes Mellitus, Type 1|Diabetes Mellitus, Type 2
Interventions: DRUG: biphasic insulin aspart 30
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: Efficacy and Safety of GMRx2 Compared to Dual Combinations for the Treatment of Hypertension
Status: COMPLETED
Conditions: Hypertension
Interventions: DRUG: Telmisartan 20 mg/amlodipine 2.5 mg/indapamide 1.25 mg|DRUG: telmisartan 40 mg/amlodipine 5 mg/indapamide 2.5 mg|DRUG: Telmisartan 20 mg/amlodipine 2.5 mg .|DRUG: telmisartan 40 mg/amlodipine 5 mg|DRUG: Telmisartan 20 mg/indapamide 1.25 mg|DRUG: telmisartan 40 mg/indapamide 2.5 mg|DRUG: Amlodipine 2.5 mg/indapamide 1.25 mg|DRUG: amlodipine 5 mg/indapamide 2.5 mg
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: A Study to Evaluate the Effectiveness, Tolerability and Safety of Laquinimod
Status: COMPLETED
Conditions: Relapsing Remitting Multiple Sclerosis
Interventions: DRUG: laquinimod 0.3|DRUG: laquinimod 0.6|OTHER: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Over-night Effect of Dietary Fiber on Glucose Metabolism and Satiety
Status: COMPLETED
Conditions: Obesity|Metabolic Syndrome
Interventions: OTHER: High levels of indigestible carbohydrates|OTHER: Low levels of indigestible carbohydrates
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: SINGLE (PARTICIPANT)|Primary Purpose: PREVENTION
Clinical trial: A ProspectiveTrial Comparing THUNDERBEAT to the Ligasure Energy Device During Laparoscopic Colon Surgery
Status: COMPLETED
Conditions: Colon Cancer
Interventions: DEVICE: THUNDERBEAT|DEVICE: LIGASURE
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: OTHER
Clinical trial: ABCB5 as a Prognostic Marker in Survival of Cultivated Limbal Stem Cell Transplantation
Status: TERMINATED
Conditions: Limbal Stem Cell Deficiency
Interventions: PROCEDURE: Pannus and conjunctival dissection|PROCEDURE: Human cultivated limbal stem cell transplantation
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Intravenous Paracetamol for Postoperative Pain
Status: COMPLETED
Conditions: Pain, Postoperative|Recovery of Function|Child
Interventions: DRUG: Paracetamol|DRUG: Placebo (for paracetamol)|DRUG: Ketoprofen|DRUG: Tramadol|DRUG: Morphine
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Severe Anemia Treatment Trials, Pakistan
Status: COMPLETED
Conditions: Anemia
Interventions: DIETARY_SUPPLEMENT: Iron-folic acid and mebendazole|DRUG: Mebendazole|DIETARY_SUPPLEMENT: Multivitamins|DRUG: Mebendazole + Multivitamin
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: FACTORIAL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Individual Differences in Placebo Analgesic Effects
Status: NOT_YET_RECRUITING
Conditions: Healthy
Interventions: BEHAVIORAL: Placebo cream- "promotion" suggestion|BEHAVIORAL: Placebo cream- "prevention" suggestion|BEHAVIORAL: Control cream
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: SINGLE (PARTICIPANT)|Primary Purpose: BASIC_SCIENCE
Clinical trial: Sampling P2Y12 Receptor Inhibition With Prasugrel and Ticagrelor in Patients Submitted to Thrombolysis
Status: COMPLETED
Conditions: Acute Coronary Syndrome|Platelet Function
Interventions: DRUG: Prasugrel|DRUG: Ticagrelor
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE
Clinical trial: Suicide Prevention Integration Into Task-shifted Mental Health Interventions
Status: RECRUITING
Conditions: Suicide|Suicide Prevention|Suicidal Ideation
Interventions: BEHAVIORAL: KPZ Program (KPZ)|BEHAVIORAL: Enhanced Usual Care (EUC)
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: PREVENTION
Clinical trial: Expanded Access of Onvansertib With FOLFIRI and Bevacizumab for the Second-Line Treatment of Participants With KRAS-Mutated Metastatic Colorectal Cancer
Status: NO_LONGER_AVAILABLE
Conditions: Metastatic Colorectal Cancer|KRAS Gene Mutation
Interventions: DRUG: Onvansertib|BIOLOGICAL: Bevacizumab|DRUG: FOLFIRI
Study Type: EXPANDED_ACCESS
Clinical trial: Octreotide Therapy in Children and Young Adults With Prader-Willi Syndrome (PWS)
Status: TERMINATED
Conditions: Prader-Willi Syndrome
Interventions: DRUG: Octreotide|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Neoadjuvant SHR-1210 Plus Apatinib for Resectable Stage III-IV Acral Melanoma
Status: RECRUITING
Conditions: Acral Melanoma
Interventions: DRUG: SHR-1210+Apatinib
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: FGF23 and Angiotensin-(1-7) in Hypophosphatemia (GAP)
Status: COMPLETED
Conditions: Hypophosphatemia|X-linked Hypophosphatemia|Renin-angiotensin System|Left Ventricular Hypertrophy
Interventions: DIAGNOSTIC_TEST: Ang II and Ang-(1-7)|DIAGNOSTIC_TEST: FGF23 and klotho
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: Efficacy and Safety of the Fixed-dose Combination Atorvastatin/Fenofibrate vs Atorvastatin in Patients With T2D and DLP.
Status: UNKNOWN
Conditions: Dyslipidemia Associated With Type II Diabetes Mellitus
Interventions: DRUG: Atorvastatin 20 mg / Fenofibrate 160 mg in fixed dose|DRUG: Atorvastatin (Lipitor ®)
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: The Use of the Transient Elastography Paediatric Probe, Compared to the M Probe, Indirect Biomarkers and Histology
Status: COMPLETED
Conditions: Elastography|Fibrosis, Liver|Pediatrics|Chronic Liver Disease
Interventions: DIAGNOSTIC_TEST: hepatic transient elastography using S probe and M probe
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: Iron Fish for Dominican Republic (DR) Infants
Status: COMPLETED
Conditions: Iron-deficiency|Iron Deficiency Anemia
Interventions: OTHER: Lucky Iron Fish (TM) - An iron ingot that is a Cooking supplement
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: PREVENTION
Clinical trial: Self Awakening and Snoozing Effects on the Cortisol Awakening Response
Status: UNKNOWN
Conditions: Cortisol Awakening Response
Interventions: BEHAVIORAL: Self Awakening - Natural Waking|BEHAVIORAL: Snooze - Natural waking
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: BASIC_SCIENCE
Clinical trial: Evaluate Long Term Cardiovascular and Pulmonary Complications After COVID-19 With Point of Care Ultrasound
Status: RECRUITING
Conditions: Covid19|Echocardiography|Ultrasound
Interventions: DIAGNOSTIC_TEST: Point of care ultrasound including echocardiography, lung ultrasound, vascular ultrasound
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: Nab-Paclitaxel to Paclitaxel in Advanced Urothelial Cancer Progressing on or After Platinum Containing Regimen.
Status: COMPLETED
Conditions: Urothelial Cancer
Interventions: DRUG: Nab-Paclitaxel|DRUG: Paclitaxel
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Vascular Lifestyle-Intervention and Screening in Pharmacy
Status: UNKNOWN
Conditions: Cardiovascular Diseases|Hypercholesterolemia|Dyslipidemia|Hypertensive Disease|Diabetes Mellitus, Type 2
Interventions: BEHAVIORAL: Information on high risk factor levels and lifestyle advice|BEHAVIORAL: No information on high risk factor levels but lifestyle advice|BEHAVIORAL: No information on high risk factor levels, nor lifestyle advice
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: SCREENING
Clinical trial: Tofacitinib in the Treatment of Rheumatoid Arthritis-related Interstitial Lung Disease.
Status: RECRUITING
Conditions: Rheumatoid Arthritis|Interstitial Lung Disease
Interventions: DRUG: Tofacitinib
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Low-dose IL-2 to the Kinetics of Regulatory T-cell in Healthy Volunteers
Status: COMPLETED
Conditions: Healthy Volunteers
Interventions: DRUG: ILT101|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: OTHER
Clinical trial: ExAblate Transcranial MR Guided Focused Ultrasound for the Treatment of Parkinson's Disease
Status: COMPLETED
Conditions: Parkinson's Disease
Interventions: DEVICE: ExAblate Transcranial MRgFUS|DEVICE: Sham ExAblate Transcranial MRgFUS
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Painful Diabetic Polyneuropathy Trial With a New Centrally Acting Analgesic
Status: COMPLETED
Conditions: Diabetic Polyneuropathy
Interventions: DRUG: GRT6005|DRUG: MS Continus®|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: New Therapy for Patients With Severe Tinnitus
Status: COMPLETED
Conditions: Tinnitus
Interventions: OTHER: Sound Based and Educational Therapies|OTHER: Integrative Medicine Therapies and Sound Based Education Therapies
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: OTHER
Clinical trial: Tenoten® in the Treatment of Somatoform, Stress-related and Other Neurotic Disorders
Status: COMPLETED
Conditions: Anxiety
Interventions: DRUG: Tenoten|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Effects of FRAX+SARC-F Pre-screening on Preventing Fragility Fracture and Fall in Community-dwelling Older Adults
Status: ACTIVE_NOT_RECRUITING
Conditions: Age Related Osteoporosis|Fall
Interventions: OTHER: FRAX+SARC-F questionnaire pre-screening
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
Clinical trial: Repeat-dose Study of Lenalidomide (Revlimid ®) Plus Dexamethasone in Patients With Lymphoblastic Leukemia
Status: COMPLETED
Conditions: Leukemia, Lymphoid|Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
Interventions: DRUG: Lenalidomide plus dexamethasone
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: The Effects of Obesity and Obstructive Sleep Apnea on Inflammation and Heart Disease
Status: COMPLETED
Conditions: Sleep Apnea Syndromes|Inflammation
Interventions: BEHAVIORAL: Weight Loss Program|DEVICE: CPAP therapy
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Occupational Therapy-Based Cognitive Rehabilitation of Cocaine Abusers: A Pilot Study
Status: COMPLETED
Conditions: Mild Cognitive Impairment, So Stated|Cocaine Use Disorder
Interventions: BEHAVIORAL: Occupational therapy-based cognitive rehabilitation|BEHAVIORAL: Psychoeducation/games
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Multi-Organ Denervation With the iRF System to RedUce Sympathetic Drive
Status: UNKNOWN
Conditions: Hypertension|Type 2 Diabetes|Metabolic Syndrome
Interventions: DEVICE: iRF System Multi-organ Denervation|OTHER: Control Procedure
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: SINGLE (PARTICIPANT)|Primary Purpose: DEVICE_FEASIBILITY
Clinical trial: Efficacy of Empagliflozin or Linagliptin as an Alternative to Metformin for Treatment of Polycystic Ovary Syndrome
Status: UNKNOWN
Conditions: Polycystic Ovary Syndrome (PCOS)
Interventions: DRUG: Empagliflozin 25 mg|DRUG: Linagliptin 10 mg|DRUG: Metformin 1500 mg
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Real-world Insights of People With Human Immunodeficiency Virus (HIV) Infection
Status: COMPLETED
Conditions: HIV Infections
Interventions: OTHER: Functional Assessment of HIV Infection|OTHER: Patient Satisfaction Questionnaire|OTHER: Symptom Distress Module|OTHER: Patient Health Questionnaire|OTHER: Internalized Stigma of AIDS Tool|OTHER: Medication adherence visual analogue scale
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: Comprehensive Care Community and Culture Study
Status: RECRUITING
Conditions: Comprehensive Care|Quality of Care|Medicare|Cost of Care
Interventions: BEHAVIORAL: Ambulatory Care Coordinator Team (ACCT)|BEHAVIORAL: Comprehensive Care Physician Program (CCP)|BEHAVIORAL: Comprehensive Care Community & Culture Program (C4P)
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: HEALTH_SERVICES_RESEARCH
Clinical trial: High-dose Chemotherapy With Transplantation of Gene-modified Haematopoietic Stem Cells for HIV-positive Patients With Malignant Diseases Indicating an HSCT
Status: TERMINATED
Conditions: AIDS-related Lymphoma|HIV Infections
Interventions: PROCEDURE: PBSC-M87o, Gene (M87o)-modified, CD34+ peripheral blood progenitor cells (PBSC)
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Efficacy and Safety of A-prexa Compared to Zyprexa in Patients With Schizophrenia
Status: COMPLETED
Conditions: Schizophrenia|Schizophreniform Disorder|Schizoaffective Disorder
Interventions: DRUG: A-prexa|DRUG: Zyprexa
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: MRI Radiomics Combined With Pathomics on the Prediction of Molecular Classification and Prognosis of Endometrial Cancer
Status: NOT_YET_RECRUITING
Conditions: Endometrial Neoplasms
Interventions: DIAGNOSTIC_TEST: next generation sequencing AND Immunohistochemical examination
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: Efficacy and Pharmacokinetic/Pharmacodynamic Parameters of Cefoxitin in Women With Acute Pyelonephritis Without Severity Symptoms Due to Extended-spectrum β-lactamase Producing Escherichia Coli
Status: TERMINATED
Conditions: Acute Pyelonephritis Without Severity Symptoms Due to ESBL-producing E.Coli
Interventions: DRUG: Cefoxitin
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Study to Evaluate the Safety and Immunogenicity of an HIV-1 Vaccine Regimen of Adjuvanted UVAX-1107 Followed by Adjuvanted UVAX-1107 or Adjuvanted UVAX-1197 in Healthy Subjects Aged 25-55 Years.
Status: ACTIVE_NOT_RECRUITING
Conditions: AIDS/HIV - RelatedDisease Associated With AIDS|Vaccine-Preventable Diseases|HIV Infections
Interventions: BIOLOGICAL: UVAX-1107|BIOLOGICAL: UVAX-1197|OTHER: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
Clinical trial: Test to Determine the Effectiveness of Moisturizing Balm Used on Babies With Dry, Itchy Skin
Status: TERMINATED
Conditions: Eczema
Interventions: DEVICE: EpiCeram Skin Barrier Emulsion|DRUG: 1% Colloidal Oatmeal Balm
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Urinary Diversion During Robotic Assisted Radical Cystectomy in Patients With Bladder Cancer
Status: WITHDRAWN
Conditions: Recurrent Bladder Cancer|Stage 0 Bladder Cancer|Stage I Bladder Cancer|Stage II Bladder Cancer|Urinary Complications
Interventions: PROCEDURE: robot-assisted laparoscopic surgery|PROCEDURE: robot-assisted laparoscopic surgery|OTHER: intraoperative complication management/prevention|OTHER: intraoperative complication management/prevention|OTHER: quality-of-life assessment
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE
Clinical trial: An Atlas of Airways at a Single Cell Level in Chronic Obstructive Pulmonary Disease, Idiopathic Pulmonary Fibrosis and Controls
Status: RECRUITING
Conditions: Pulmonary Disease, Chronic Obstructive|Interstitial Pulmonary Fibrosis
Interventions: PROCEDURE: Bronchoscopy
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: BASIC_SCIENCE
Clinical trial: Study to Evaluate the Feasibility of [18F]Florbetapir PET for Assessment in MS Patients
Status: COMPLETED
Conditions: Multiple Sclerosis
Interventions: DRUG: [18F]Florbetapir PET imaging
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: OTHER
Clinical trial: A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Once-daily Oral Avatrombopag in Japanese Subjects With Chronic Liver Diseases and Thrombocytopenia
Status: COMPLETED
Conditions: Thrombocytopenia Associated With Chronic Liver Disease
Interventions: DRUG: avatrombopag|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Treatment of Aggressive Behavior and Post-Traumatic Stress Disorder
Status: COMPLETED
Conditions: Aggressive Behavior|Post-Traumatic Stress Disorder
Interventions: BEHAVIORAL: Narrative Exposure Therapy for violent offenders (NETvo)
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Value of PET/MR Enterography in the Assessment of Crohn's Disease Using a Collagen-binding Radiotracer.
Status: RECRUITING
Conditions: Crohn Disease
Interventions: DRUG: Radiotracer Injection|DRUG: Contrast Media, Magnetic Resonance|DIAGNOSTIC_TEST: Blood Draw|DRUG: Glucagon|DIAGNOSTIC_TEST: Imaging|DRUG: Oral contrast media application
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: Effect of Intraoperative IV Ketamine on Postoperative Morphine Consumption During Intestinal Surgery
Status: UNKNOWN
Conditions: Postoperative Analgesia
Interventions: DRUG: Ketamine Hydrochloride|DRUG: Normal saline
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (INVESTIGATOR)|Primary Purpose: PREVENTION
Clinical trial: A Study Comparing the Efficacy of TA103 and the Placebo Control in the Treatment of Interdigital Tinea Pedis.
Status: COMPLETED
Conditions: Tinea Pedis
Interventions: DRUG: TA103|DRUG: Placebo Control
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Phase 2, Multi-center, Randomized, Double- Masked and Placebo-Controlled Study of YP-P10 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye (ICECAP 1)
Status: COMPLETED
Conditions: Dry Eye
Interventions: DRUG: 0.3% YP-P10 Ophthalmic Solution|DRUG: 1% YP-P10 Ophthalmic Solution|DRUG: YP-P10 Placebo Ophthalmic Solution (vehicle)
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Evaluating the Efficacy and Safety of the VERAFLO™ Dressing Kit for Wound Bed Preparation in Open Wounds
Status: RECRUITING
Conditions: Wound Healing
Interventions: DEVICE: Experimental: Investigational device: V.A.C. VERAFLO™ Dressing Kit|DEVICE: Active Comparator: Dressing Name: Negative pressure wound drainage material
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: A Collaborative Community Effort Using Belantamab Mafodotin in Relapsed/Refractory Myeloma
Status: NOT_YET_RECRUITING
Conditions: Relapsed/Refractory Multiple Myeloma
Interventions: DRUG: Belantamab mafodotin
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Cannabidiol as an Adjunctive Treatment for Bipolar Depression
Status: TERMINATED
Conditions: Bipolar Disorder|Bipolar Depression|Bipolar Affective Disorder
Interventions: DRUG: Cannabidiol|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: A Multicenter, Retrospective Observational Study to Evaluate the Effectiveness and Safety of Polatuzumab Vedotin
Status: UNKNOWN
Conditions: Diffuse Large B-Cell Lymphoma (DLBCL)
Interventions: DRUG: Polatuzumab Vedotin-Piiq
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: Comparative Clinical Evaluation of BioFlx, Zirconia, and Stainless-Steel Crowns in Primary Molars
Status: RECRUITING
Conditions: Dental Restoration
Interventions: OTHER: Preformed stainless steel crown.|OTHER: Preformed zirconia crown|OTHER: Preformed BioFlx crown
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: OTHER
Clinical trial: Personalized Nutrition Therapy Using Continuous Glucose Monitoring to Improve Outcomes in Type 2 Diabetes Mellitus
Status: RECRUITING
Conditions: Type 2 Diabetes
Interventions: DEVICE: Unblinded CGM plus nutrition therapy|BEHAVIORAL: Nutrition therapy only
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: SUPPORTIVE_CARE
Clinical trial: Investigation of the Neurovegetative Pattern in Patients With Thoracic Aortic Aneurysms (TAA)
Status: RECRUITING
Conditions: Rare Diseases|Aortic Aneurysm, Thoracic
Interventions: DIAGNOSTIC_TEST: Supine resting (REST) and active standing (STAND)
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: Massage Therapy for Cancer-Related Fatigue
Status: COMPLETED
Conditions: Breast Neoplasms|Ovarian Neoplasms|Prostatic Neoplasms|Colorectal Neoplasms
Interventions: PROCEDURE: Moderate-intensity and low-intensity bodywork therapy
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: A Study Characterizing Pharmacodynamic Profiles in Subjects With Chronic Obstructive Pulmonary Disease
Status: COMPLETED
Conditions: Chronic Obstructive Pulmonary Disease (COPD)
Interventions: DRUG: Formoterol Fumarate|DRUG: Formoterol Fumarate|DRUG: Formoterol Fumarate|DRUG: Foradil Aerolizer|DRUG: Foradil Aerolizer
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Effect Of Multiple Biofortified Food Crops On Micronutrient Status And Immune Function Among Indian Infants and Their Mothers
Status: ACTIVE_NOT_RECRUITING
Conditions: Vitamin A Deficiency|Iron Deficiency|Zinc Deficiency
Interventions: OTHER: Multiple biofortified food crops (MBFC-Exp)|OTHER: Commercially available non-fortified food crops (MBFC-C)
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: OTHER
Clinical trial: Effectiveness of Invasive Electrostimulation Combined With an Exercise Program in Plantar Fasciitis
Status: COMPLETED
Conditions: Fasciitis, Plantar
Interventions: PROCEDURE: Invasive electrostimulation combined with exercises|PROCEDURE: Placebo electrostimulation and exercises
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Biventricular Pacing in Hypertrophic Cardiomyopathy After Aortic Valve Replacement
Status: COMPLETED
Conditions: Hypertrophic Cardiomyopathy
Interventions: PROCEDURE: additional temporary pacewire
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: The Effect of Breast Milk Smell on Nutrition in Preterms
Status: UNKNOWN
Conditions: Breast Milk|Digestion|Nutrition|Smell Stimulation|Preterm Birth
Interventions: BEHAVIORAL: Olfactory stimulation
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: SUPPORTIVE_CARE
Clinical trial: Trail Evaluating Particle Therapy With or Without Apatinib for H&N Adenoid Cystic Carcinoma
Status: UNKNOWN
Conditions: Adenoid Cystic Carcinoma
Interventions: DRUG: Apatinib|RADIATION: Particle Therapy
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Patients Treated by the Danish Emergency Medical Services Following Non-drowning Water Rescues From 2016 to 2023
Status: NOT_YET_RECRUITING
Conditions: Drowning|Drowning, Near|Submersion|Submersion - Accidental|Submersion or Drowning Due to Being Washed Overboard|Submersion or Drowning Due to Being Thrown Overboard|Submersion or Drowning Due to Ship Sinking, Water Skier Injured|Submersion or Drowning Due to Boat Submerging, Swimmer Injured|Submersion or Drowning Due to Boat Overturning, Swimmer Injured|Submersion or Drowning Due to Boat Submerging, Water Skier Injured|Submersion or Drowning Due to Fall From Gangplank, Swimmer Injured|Submersion or Drowning Due to Ship Sinking, Docker or Stevedore Injured|Submersion or Drowning Due to Fall Overboard, Docker or Stevedore Injured
Interventions: OTHER: Submersion or immersion in liquid
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: Bioequivalence Study of Cyproterone Acetate and Ethinyl Estradiol in Healthy Female Volunteers
Status: COMPLETED
Conditions: Drug Use
Interventions: DRUG: Elzsa film-coated tablet|DRUG: Diane-35 Sugar-coated tablet
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: BASIC_SCIENCE
Clinical trial: Augmentation of Screening Colonoscopy With Fecal Immunochemical Testing
Status: UNKNOWN
Conditions: Colon Cancer
Interventions: DEVICE: Fecal Immunochemical Testing|DEVICE: Fecal Immunochemical Testing
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: SCREENING
Clinical trial: The Effect of Soft Orthoses on Balance and Gait Performance in Children With Cerebral Palsy
Status: COMPLETED
Conditions: Cerebral Palsy
Interventions: OTHER: Conventional Physical Therapy Protocol|OTHER: TheraTog orthotic undergarment with its strapping system
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: A Study of FMT in Patients With AML Allo HSCT in Recipients
Status: COMPLETED
Conditions: Acute Myeloid Leukemia|Allogeneic Hematopoietic Cell Transplantation
Interventions: BIOLOGICAL: Fecal Microbiota Transplant (FMT)|OTHER: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: The Effect of 12-week Circuit Training on Insulin Sensitivity and Endothelial Function in Women With Insulin Resistance
Status: ACTIVE_NOT_RECRUITING
Conditions: Insulin Resistance
Interventions: BEHAVIORAL: Circuit training (combination of strength and endurance exercises)
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (CARE_PROVIDER)|Primary Purpose: BASIC_SCIENCE
Clinical trial: Enhanced Recovery After Surgery Protocal Versus Traditional Care in Laparoscopic Hepatectomy
Status: COMPLETED
Conditions: Liver Diseases
Interventions: PROCEDURE: ERAS perioperative cares|PROCEDURE: Conventional perioperative cares
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT
Clinical trial: Curcumin (Tumeric) in the Treatment of Irritable Bowel Syndrome: A Randomized-Controlled Trial
Status: COMPLETED
Conditions: Irritable Bowel Syndrome
Interventions: DIETARY_SUPPLEMENT: curcumin|DIETARY_SUPPLEMENT: placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Efficacy Study on Symptomatic Control of Patient With Knee Osteoarthritis Between 14% of Plai (Plaivana®) to Placebo Gels
Status: COMPLETED
Conditions: Knee Osteoarthritis
Interventions: DRUG: Plavina cream
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: A Phase 3 Clinical Study to Evaluate Lemzoparlimab for Injection in Combination With Azacitidine (AZA) Versus AZA Monotherapy in Treatment-naïve Patients With Higher-risk Myelodysplastic Syndrome (MDS)
Status: RECRUITING
Conditions: Myelodysplastic Syndromes(MDS)
Interventions: DRUG: Lemzoparlimab+Azacitidine (AZA)|DRUG: Azacitidine (AZA)
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: A 3-month Study to Assess the Safety and Effectiveness of ONS-5010 in Subjects With Neovascular Age-related Macular Degeneration (AMD)
Status: RECRUITING
Conditions: Neovascular Age-related Macular Degeneration|Age-Related Macular Degeneration|Wet Macular Degeneration
Interventions: BIOLOGICAL: bevacizumab|BIOLOGICAL: ranibizumab
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: A Clinical Study of Alanyl-Glutamine for Reduction of Post-Myomectomy Adhesions
Status: COMPLETED
Conditions: Pelvic Adhesions
Interventions: DRUG: L-Alanyl/L-Glutamine|DRUG: Physiologic saline
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
Clinical trial: Exploratory Study of Danicamtiv in Patients With Primary Dilated Cardiomyopathy (DCM) Due to Genetic Variants or Other Causalities
Status: TERMINATED
Conditions: Primary Familial Dilated Cardiomyopathy
Interventions: DRUG: danicamtiv
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Study to Evaluate the Treatment Effect of PT003 on Cardiovascular Hemodynamics in Subjects With Moderate to Severe COPD
Status: TERMINATED
Conditions: COPD
Interventions: DRUG: GFF MDI (PT003)|DRUG: Placebo MDI
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Dual-Orexin Antagonism As a Mechanism for Improving Sleep and Drug Abstinence in Opioid Use Disorder
Status: ACTIVE_NOT_RECRUITING
Conditions: Opioid-use Disorder|Sleep
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: BASIC_SCIENCE
Clinical trial: Taletrectinib in Previously Treated Metastatic CDH1-mutated Invasive Lobular Cancer (ILC)
Status: SUSPENDED
Conditions: Breast Cancer|Metastatic Breast Cancer
Interventions: DRUG: Taletrectinib
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Effects of Tirzepatide and Insulin Glargine on Glucolipid Metabolism and Brain Function in Patients With Type 2 Diabetes
Status: RECRUITING
Conditions: Type 2 Diabetes Mellitus
Interventions: DRUG: Tirzepatide|DRUG: Insulin Glargine
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Study of FibroGen (FG)-3019 in Subjects With Type 2 Diabetes Mellitus and Kidney Disease on ACEi and/or ARB Therapy
Status: TERMINATED
Conditions: Type 2 Diabetes Mellitus|Diabetic Nephropathy|Diabetic Kidney Disease
Interventions: DRUG: FG-3019|DRUG: FG-3019|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Combined Peripheral (BreEStim) and Central Electrical Stimulation (tDCS) for Neuropathic Pain Management - Spinal Cord Injury
Status: COMPLETED
Conditions: Pain Management
Interventions: DEVICE: BreEStim|DEVICE: tDCS|DEVICE: tDCS sham
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT
Clinical trial: A Pharmacokinetic Study of Trabectedin in Patients With Advanced Malignancies and Hepatic Dysfunction
Status: COMPLETED
Conditions: Neoplasm Metastases|Hepatic Insufficiency
Interventions: DRUG: Trabectedin|DRUG: Dexamethasone
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Evaluation of the Inhibitory Effect of 5 Anti-Histamines in Urticaria
Status: COMPLETED
Conditions: Urticaria
Interventions: DRUG: Cetirizine|DRUG: Desloratadine|DRUG: Fexofenadine|DRUG: Ebastine|DRUG: Bilastine
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT